Literature DB >> 12705677

Study of developed resistance due to antibiotic treatment of coagulase-negative Staphylococci.

Anders Tegnell1, Katarzyna Grabowska, Anders Jacobsson, Mikael Andersson, Johan Giesecke, Lena Ohman.   

Abstract

Coagulase-negative Staphylococci (CoNS) are a major cause of postoperative infections. These infections are often associated with foreign material implants and/or a compromised immune system in the patient. Multiresistant strains are increasingly common in the hospital environment and there is concern that the infections will become difficult or impossible to treat. This report is based on a study of 75 patients, with postoperative infections caused by CoNS after thoracic surgery. All patients were treated with surgical revision and antibiotic therapy. One or more bacterial cultures were made in each case, and the resistance pattern of the CoNS found was determined. The goal of the study was to evaluate possible relationships between antibiotic therapy and the appearance of resistance to antibiotics in CoNS found. To describe this relationship, three models were constructed and analyzed by multiple logistic regression. The results indicate an increased resistance to beta-lactam antibiotics and clindamycin after the use of cephalosporins. Also, the use of vancomycin or vancomycin in combination with rifampicin or fusidic acid increases the risk for development of resistance to beta-lactam antibiotics, ciprofloxacin, fusidic acid, clindamycin, netilmycin, and rifampicin. The hypothesis that a combination of antibiotics will curtail the development of resistance was not supported in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705677     DOI: 10.1089/107662903764736283

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  3 in total

1.  Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.

Authors:  Leonard E Weisman; Helen M Thackray; Joseph A Garcia-Prats; Mirjana Nesin; Joseph H Schneider; Jennifer Fretz; John F Kokai-Kun; James J Mond; William G Kramer; Gerald W Fischer
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

2.  Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.

Authors:  Ryan Tewhey; Bing Gu; Theodoros Kelesidis; Carmen Charlton; April Bobenchik; Janet Hindler; Nicholas J Schork; Romney M Humphries
Journal:  mBio       Date:  2014-05-13       Impact factor: 7.786

3.  Anti-Inflammatory Activity of the Essential Oil Citral in Experimental Infection with Staphylococcus aureus in a Model Air Pouch.

Authors:  Hellen Braga Martins; Nathan das Neves Selis; Clarissa Leal Silva E Souza; Flávia S Nascimento; Suzi Pacheco de Carvalho; Lorena D'Oliveira Gusmão; Jannine Dos Santos Nascimento; Anne Karoline Pereira Brito; Samira Itana de Souza; Marcio Vasconcelos de Oliveira; Jorge Timenetsky; Regiane Yatsuda; Ana Paula T Uetanabaro; Lucas M Marques
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-21       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.